Deciphera Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Deciphera Pharmaceuticals generated cash of -$146,697,000, which is more than the previous year. Cash used in financing activities reached the amount of $152,004,000 last year. Net change in cash is therefore $18,766,000.
Cash Flow
| 2015 | -13.26M | -142K | 38.41M |
|---|---|---|---|
| 2016 | -23.09M | -223K | 54.99M |
| 2017 | -36.70M | -406K | 176.40M |
| 2018 | -86.78M | -2.19M | 185.98M |
| 2019 | -149.29M | -460.52M | 436.37M |
| 2020 | -239.68M | 28.45M | 226.80M |
| 2021 | -240.82M | 176.84M | 14.89M |
| 2022 | -152.86M | -34.30M | 164.99M |
| 2023 | -146.69M | 12.54M | 152.00M |
DCPH Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 64.74M | 87.06M | 135.89M | 120.32M | 293.76M | 196.75M | 57.46M | 25.77M | 770K |
Operating activities | |||||||||
Net income | -194.94M | -178.93M | -299.96M | -266.48M | -192.25M | -99.85M | -50.28M | -25.94M | -19.81M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 2.1M | 2.94M | 3.01M | 2.30M | 830K | 317K | 150K | 90K | 73K |
Stock-based compensation expense | 50.60M | 51.94M | 46.07M | 37.13M | 20.41M | 0 | 4.86M | 1.48M | 2.55M |
| Deferred income tax benefit | 50.60M | 51.94M | 46.07M | 37.13M | 20.41M | 0 | 4.86M | 1.48M | 2.55M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -9.34M | -1.78M | -6.69M | -13.89M | 0 | 0 | 0 | 0 | 0 |
Inventories | -386K | -7.10M | -10.15M | -3.24M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 7.77M | 5.31M | 833K | -7.53M | 10.86M | 3.99M | 2.90M | -187K | 1.17M |
Cash generated by operating activities | -146.69M | -152.86M | -240.82M | -239.68M | -149.29M | -86.78M | -36.70M | -23.09M | -13.26M |
Investing activities | |||||||||
Purchases Of Investments | -322.57M | -322.76M | -335.37M | -1.09B | -817.14M | -1.06M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -778K | -841K | -5.97M | -5.31M | -4.93M | -1.12M | -406K | -223K | -142K |
Acquisitions Net | -13.32M | 33.46M | -4M | 7K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 12.54M | -34.30M | 176.84M | 28.45M | -460.52M | -2.19M | -406K | -223K | -142K |
Financing activities | |||||||||
Common Stock Issued | 149.74M | 163.77M | 8.58M | 226.80M | 432.4M | 185.93M | 129.11M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -187K | 0 | -198K | 0 |
Cash used in financing activities | 152.00M | 164.99M | 14.89M | 226.80M | 436.37M | 185.98M | 176.40M | 54.99M | 38.41M |
Net Change In Cash | 18.76M | -22.32M | -48.83M | 15.57M | -173.44M | 97.01M | 139.29M | 31.68M | 25.00M |
Cash at end of period | 83.50M | 64.74M | 87.06M | 135.89M | 120.32M | 293.76M | 196.75M | 57.46M | 25.77M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |